COMP <GO>
PRCT vs SGP // GROSS PROFIT MARGIN
PROCEPT BioRobotics Corporation (NASDAQ) VS. SpyGlass Pharma Inc. (NASDAQ) • 15-METRIC TALLY: PRCT 2
— SGP 2
■ METRIC PARITY
LAST: $20.30 (+0.50%) • MKT CAP: $1.16B
gross-margins
63.70%
LAST: $32.51 (-1.06%) • MKT CAP: $1.09B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRCT VS. SGP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRCT | SGP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 63.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.02% | -3.08% | -1.94 | SGP | /fcf-yield <GO> |
| Operating Margin | -33.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 37.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.98 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | PRCT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.7 | 71.4 | -20.67 | SGP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.16B | $1.09B | $75.3M | PRCT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRCT REV | SGP REV | PRCT GROSS % | SGP GROSS % | PRCT FCF | SGP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $308.1M | $0 | 63.7% | — | -$58.3M | -$33.5M |
| FY 2024 | $224.5M | $0 | 61.1% | — | -$103.6M | -$24.0M |
| FY 2023 | $136.2M | — | — | — | -$108.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRCT // BETA —
SGP // BETA —